Cargando…
Is high-dose glucocorticoid beneficial in COVID-19?
High-dose glucocorticoids are not currently recommended for treating severe COVID-19 pneumonia https://bit.ly/39VQ3O8
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842156/ https://www.ncbi.nlm.nih.gov/pubmed/33509962 http://dx.doi.org/10.1183/13993003.00065-2021 |
_version_ | 1783643955196329984 |
---|---|
author | Muthu, Valliappan Sehgal, Inderpaul Singh Prasad, Kuruswamy Thurai Agarwal, Ritesh |
author_facet | Muthu, Valliappan Sehgal, Inderpaul Singh Prasad, Kuruswamy Thurai Agarwal, Ritesh |
author_sort | Muthu, Valliappan |
collection | PubMed |
description | High-dose glucocorticoids are not currently recommended for treating severe COVID-19 pneumonia https://bit.ly/39VQ3O8 |
format | Online Article Text |
id | pubmed-7842156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-78421562021-02-01 Is high-dose glucocorticoid beneficial in COVID-19? Muthu, Valliappan Sehgal, Inderpaul Singh Prasad, Kuruswamy Thurai Agarwal, Ritesh Eur Respir J Agora High-dose glucocorticoids are not currently recommended for treating severe COVID-19 pneumonia https://bit.ly/39VQ3O8 European Respiratory Society 2021-04-15 /pmc/articles/PMC7842156/ /pubmed/33509962 http://dx.doi.org/10.1183/13993003.00065-2021 Text en Copyright ©The authors 2021. https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Agora Muthu, Valliappan Sehgal, Inderpaul Singh Prasad, Kuruswamy Thurai Agarwal, Ritesh Is high-dose glucocorticoid beneficial in COVID-19? |
title | Is high-dose glucocorticoid beneficial in COVID-19? |
title_full | Is high-dose glucocorticoid beneficial in COVID-19? |
title_fullStr | Is high-dose glucocorticoid beneficial in COVID-19? |
title_full_unstemmed | Is high-dose glucocorticoid beneficial in COVID-19? |
title_short | Is high-dose glucocorticoid beneficial in COVID-19? |
title_sort | is high-dose glucocorticoid beneficial in covid-19? |
topic | Agora |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842156/ https://www.ncbi.nlm.nih.gov/pubmed/33509962 http://dx.doi.org/10.1183/13993003.00065-2021 |
work_keys_str_mv | AT muthuvalliappan ishighdoseglucocorticoidbeneficialincovid19 AT sehgalinderpaulsingh ishighdoseglucocorticoidbeneficialincovid19 AT prasadkuruswamythurai ishighdoseglucocorticoidbeneficialincovid19 AT agarwalritesh ishighdoseglucocorticoidbeneficialincovid19 |